Nurix Therapeutics Balance Sheet (2019-2026)

Reported Financials

Nurix Therapeutics Quarterly Balance Sheet

Periods 28 quarters

Latest May 2026

Nurix Therapeutics reported total assets of $535.54M and total liabilities of $132.91M for the quarter ended May 2026, down 9.5% year over year. This balance sheet covers 28 quarters of results from Aug 2019 through May 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet	Aug2021	Nov2021	Feb2022	May2022	Aug2022	Nov2022	Feb2023	May2023	Aug2023	Nov2023	Feb2024	May2024	Aug2024	Nov2024	Feb2025	May2025	Aug2025	Nov2025	Feb2026	May2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	147.44M	80.51M	78.78M	41.53M	47.56M	64.47M	33.57M	58.96M	42.30M	54.63M	49.81M	116.79M	99.04M	110.00M	75.92M	84.26M	78.44M	246.96M	71.19M	67.69M
Short-term InvestmentsInvestments (Current)	196.46M	215.21M	183.20M	255.75M	296.92M	244.67M	243.57M	222.22M	216.55M	233.28M		326.35M	349.01M	499.59M	473.76M	401.52M	350.39M	345.98M	469.54M	375.84M
Cash & Current Investments	343.90M	295.70M	261.98M	297.28M	344.48M	309.14M	277.15M	281.18M	258.85M	287.91M	49.81M	443.14M	448.05M	609.58M	549.68M	485.78M	428.83M	592.94M	540.73M	443.53M
Receivables - NetNet Receivables		6.00M	6.00M						2.00M							19.00M
Receivables - OtherOther Receivables	5.00M
Receivables		6.00M	6.00M						2.00M							19.00M
Prepaid Assets	9.34M	9.19M	10.30M	9.51M	10.39M	9.31M	11.18M	8.84M	7.10M	7.59M	6.98M	7.08M	7.99M	9.80M	14.02M	10.55M	11.77M	13.88M	13.66M	12.95M
Current Assets	358.44M	311.12M	280.48M	306.79M	354.87M	318.45M	288.33M	290.01M	267.95M	295.50M	250.97M	450.22M	456.04M	619.39M	563.70M	515.33M	440.60M	606.82M	554.39M	456.48M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)	9.57M	11.34M	13.52M	15.51M	16.50M	17.16M	17.72M	18.50M	16.58M	16.81M	17.87M	18.56M	17.07M	17.76M	18.45M	18.77M	20.50M	22.49M	21.70M	20.01M
Long-Term Investments	121.48M	137.19M	123.69M	51.54M	69.12M	63.88M	48.45M	27.46M	9.88M	7.42M		9.38M	9.47M
Other Non-Current Assets	3.29M	2.83M	0.90M	0.90M	0.90M	0.90M	0.90M	0.90M	0.90M	0.90M	0.90M	0.90M	0.90M	3.16M	0.90M	0.90M	7.38M	7.34M	7.41M	7.98M
Non-Current Assets	134.63M	165.65M	157.24M	87.52M	104.47M	98.31M	81.83M	60.61M	40.25M	60.09M	61.70M	60.81M	57.56M	49.96M	51.34M	76.22M	81.87M	81.32M	81.74M	79.06M
Assets	493.07M	476.77M	437.72M	394.31M	459.34M	416.76M	370.15M	350.62M	308.19M	355.60M	312.67M	511.03M	513.60M	669.34M	615.04M	591.55M	522.47M	688.13M	636.13M	535.54M
Liabilities
Current Liabilities
Accounts Payables	3.86M	6.65M	6.01M	6.14M	6.05M	5.06M	5.63M	4.53M	2.19M	6.40M	5.92M	2.81M	3.92M	11.48M	8.40M	5.95M	8.61M	11.21M	10.29M	12.21M
Payables	3.86M	6.65M	6.01M	6.14M	6.05M	5.06M	5.63M	4.53M	2.19M	6.40M	5.92M	2.81M	3.92M	11.48M	8.40M	5.95M	8.61M	11.21M	10.29M	12.21M
Accumulated Expenses	11.57M	14.55M	11.42M	19.73M	19.61M	22.43M	15.39M	18.09M	21.91M	24.97M	28.32M	23.26M	27.83M	37.99M	44.36M	37.01M	43.96M	54.85M	59.95M	43.27M
Other Accumulated Expenses	0.63M	0.66M	0.55M	2.24M	1.65M	1.50M	1.02M	1.24M	0.83M	0.75M	0.74M	1.00M	0.66M	2.27M	2.69M	1.04M	1.73M	2.10M	1.93M	1.30M
Current Taxes	0.04M	0.07M	0.05M	0.03M	0.04M
Current Deferred Revenue	35.25M	41.21M	43.19M	41.32M	36.34M	37.63M	38.30M	44.06M	32.04M	48.10M	46.08M	46.77M	48.00M	38.36M	30.59M	27.42M	25.99M	17.58M	18.75M	13.32M
Total Current Liabilities	50.68M	66.26M	66.05M	72.67M	67.50M	70.66M	64.88M	72.26M	61.49M	86.96M	87.62M	80.78M	86.30M	95.85M	89.99M	75.61M	82.35M	86.47M	92.20M	72.02M
Non-Current Liabilities
Non-Current Deffered Revenue	66.38M	59.02M	55.43M	45.86M	41.55M	35.97M	26.12M	14.68M	10.24M	45.02M	34.46M	38.67M	29.86M	26.21M	24.15M	21.64M	15.18M	10.01M	7.58M	5.97M
Preferred Stock Liabilities
Operating Leases		9.19M	10.33M	9.04M	7.75M	6.43M	5.11M	3.76M	2.64M	23.12M	21.85M	20.89M	20.59M	20.29M	19.98M	46.70M	52.70M	52.91M	55.45M	54.92M
Other Non-Current Liabilities	0.80M
Total Non-Current Liabilities	117.06M
Total Liabilities	117.86M	134.47M	131.80M	127.57M	116.79M	113.06M	96.10M	90.70M	74.38M	155.10M	143.93M	140.34M	136.74M	142.35M	134.13M	143.95M	150.22M	149.39M	155.24M	132.91M
Shareholder's Equity
Common Equity	375.22M	342.30M	305.92M	266.74M	342.55M	303.70M	274.05M	259.92M	233.82M	200.49M	168.75M	370.69M	376.86M	526.99M	480.92M	447.60M	372.25M	538.75M	480.89M	402.63M
Liabilities and Shareholders Equity	493.07M	476.77M	437.72M	394.31M	459.34M	416.76M	370.15M	350.62M	308.19M	355.60M	312.67M	511.03M	513.60M	669.34M	615.04M	591.55M	522.47M	688.13M	636.13M	535.54M
Retained Earnings	-183.20M	-220.89M	-263.43M	-308.83M	-354.54M	-401.25M	-442.00M	-466.30M	-503.24M	-545.20M	-586.72M	-631.30M	-680.22M	-738.77M	-795.12M	-838.60M	-925.00M	-1003.23M	-1100.00M	-1200.00M

Nurix Therapeutics Balance Sheet API

Pull Nurix Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=NRIX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "NRIX", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=NRIX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

Nurix Therapeutics NRIX Balance Sheet (2019-2026)

Nurix Therapeutics Quarterly Balance Sheet

Nurix Therapeutics Balance Sheet API

Create an account

Sign In

Reset Password